Skip to main content
. 2021 Dec 15;43(14):1416–1424. doi: 10.1093/eurheartj/ehab863

Figure 3.

Figure 3

(A) Effects of anacetrapib on first major coronary event during the in-trial, post-trial, and overall follow-up periods. (B) Effect of anacetrapib on major coronary events by year of follow-up. Figure legend as for Figure 2. P-value for trend across rate ratios by year of first event = 0.01. CI, confidence interval.